Chiusura precedente | 24,00 |
Aperto | 24,08 |
Denaro | 23,88 x 0 |
Lettera | 24,44 x 0 |
Min-Max giorno | 23,97 - 24,23 |
Intervallo di 52 settimane | 22,73 - 30,29 |
Volume | |
Media Volume | 380.000 |
Capitalizzazione | 10,903B |
Beta (5 anni mensile) | 0,98 |
Rapporto PE (ttm) | 27,11 |
EPS (ttm) | 0,89 |
Prossima data utili | N/D |
Rendimento e dividendo (forward) | 0,53 (2,21%) |
Data ex dividendo | 05 lug 2022 |
Stima target 1A | N/D |
PRESS RELEASE Neuilly-sur-Seine, France – June 28, 2022 Bureau Veritas acquires Advanced Testing Laboratory, a US leader in scientific sourcing Expanding BV’s footprint in Consumer Products and Consumer Healthcare markets Bureau Veritas, a world leader in testing, inspection and certification, announced the acquisition of Advanced Testing Laboratory (ATL), a leader in scientific sourcing services for the North American Consumer Healthcare Products, Cosmetics & Personal Care and Medical Device ma
PRESS RELEASE Neuilly-sur-Seine, France – 27 June 2022 Information related to the elements of compensation ofthe Chief Executive Officer Published pursuant to the recommendations of the AFEP-MEDEF Corporate Governance Code of Listed Corporations As part of its remuneration policy, Bureau Veritas grants options to subscribe or to purchase shares (“Options”) and Performance shares (“Shares”) to a number of Group employees around the world. On 14 June 2022, the Board of Directors decided to grant O
PRESS RELEASE Neuilly-sur-Seine, France – June 24, 2022 ORDINARY SHAREHOLDERS' MEETING OF JUNE 24, 2022: All submitted resolutions were adopted The Ordinary Shareholders’ Meeting (the "Shareholders’ Meeting") of Bureau Veritas (the "Company"), chaired by Mr. Aldo Cardoso, Chairman of the Board of Directors, was held today at the Company’s head office. All the resolutions submitted to the Shareholders’ Meeting were adopted, including: The approval of the statutory and consolidated financial state